Scientists Discover New Approach to Polio Vaccine Production

0
23
No votes yet.
Please wait...

Scientists have identified new ways to provide vaccines against polio, which do not require the growth of live virus for their manufacture.

Despite the success of vaccines produced from ‘virus-like particles’ (VLPs) for hepatitis B and human papilloma viruses, poliovirus VLPs have proved to be too unstable to make practical vaccines.

Now, a research team at the University of Leeds has found a new way to modify these VLPs, also known as ‘empty capsids’ by identifying mutations which make their structures sufficiently stable to act as vaccines.

Polio is on the verge of being eradicated world-wide, but even when it has been officially declared extinct as a disease, governments will need to continue to vaccinate to ensure against its recurrence.

The Leeds team and collaborators say this form of vaccine, using the newly developed stabilised VLPs, would be best used after the virus has been eradicated.

A Professor of Molecular Virology and co-leader of the study at the University, David Rowlands, said that continuing to vaccinate after polio has been eradicated is essential to prevent the disease from recurring, but there are significant bio-safety concerns about current production methods.

“Our new method of creating the vaccine has been proven to work in lab conditions and on top of that we’ve proved it’s actually more stable than existing vaccines.

“The improved stability of these modified VLPs means that they can be produced using bio-engineering techniques without involving the growth of live virus”.

This study was a lab experiment, which shows stabilised VLPs to be effective in a controlled environment. Further research using animals (rats and mice) is planned, as part of the essential process of making sure the new VLPs are safe and effective for use in humans.

Prof. Nicola Stonehouse, co-leader of the study, from the University of Leeds also stated that the international drive to eradicate polio using existing vaccines continues, but methods need to be found to maintain vaccination safely as insurance after it appears to have been eradicated. This is when our approach will come into its own.

Facebook Comments
No votes yet.
Please wait...

Comments

comments

SHARE
Content Developer at Healthfacts.ng. I am a passionate blogger, internet and health enthusiast. I love photography and graphics design and exploring is my thing. iDesign, iShoot, iWrite.

LEAVE A REPLY